NRX Pharmaceuticals, Inc.NP
SEC Form D filing

NRX Pharmaceuticals, Inc.

Biotech · Series A · Regulation D 506(b) · DE · Filed March 6, 2025

Offering amount
$3.5M
Exemption
Reg D 506(b)
Issuer state
DE
Filing date
March 6, 2025
Signature date
—
CIK
0001719406

Summary

NRX Pharmaceuticals with $3.5M offering; biotech pharma company in series-a range.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.